Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

News and Opinion from the Pandemic Sciences Institute at the University of Oxford

Sarah Gilbert receives Royal Society of Chemistry Honorary Fellowship

PSI Principal Investigator Professor Dame Sarah Gilbert has been made an Honorary Fellow of the Royal Society of Chemistry.

Speakers announced for this year’s International Pandemic Sciences Conference

Meet the global experts set to present on the latest scientific advancements that will predict, identify and control future epidemic and pandemic threats.

Up to £16.5 million awarded to global consortium to overcome obstacles in infectious disease research

The International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) has been awarded up to £16.5 million to build on its globally-recognised efforts to prevent illness and deaths from epidemic-prone infectious diseases.

New science partnership to strengthen Africa’s pandemic resilience

A groundbreaking research partnership is set to enhance Africa’s preparedness and response to future health crises.

RECOVERY trial team win NIHR Impact Prize

Co-led by PSI Director Professor Sir Peter Horby, the RECOVERY trial was defined "one of the most well-known studies supported by the NIHR with clear national and global impact”.

Prioritising research to better address high-consequence outbreaks

A new paper published in BMC Medicine analyses research prioritisation approaches for high-consequence pathogens.

New paper outlines ethical issues in clinical metagenomics

This week, University of Oxford researchers published the first paper mapping clinical ethics questions raised by new metagenomic techniques for diagnosing disease in clinical practice.

Extended abstract deadline for International Pandemic Sciences Conference 2025

The deadline for abstract submissions and bursary applications for the International Pandemic Sciences Conference 2025  has been extended to 23:59 GMT on Wednesday 26 February.

Advances in AI can help prepare the world for the next pandemic

In the first study of this kind, PSI and Oxford researchers partner with global colleagues to outline how Artificial Intelligence can transform infectious disease research and save more lives.

New partnership to advance public health and life science research collaboration in West Africa

PSI and Institut Pasteur de Dakar (IPD) will cooperate on developing vaccines and rapid diagnostics – as well as strengthening workforce in the vaccinology, clinical trials and biomanufacturing sectors.

Abstract submissions open for International Pandemic Sciences Conference 2025

Abstract and bursary submissions are now open for the International Pandemic Sciences Conference 2025 – Getting Ahead of the Curve.

Study provides new insights into mpox clinical outcomes and transmission

Results of MOSAIC, a European observational study led by researchers at PSI and ISARIC, provides evidence on how the clade IIb mpox virus affects patients and the risks of onward transmission.

Pig research paves way for human respiratory vaccine development

A study in pigs, which shows that inhaled vaccines could potentially reduce viral transmission and improve efficiency, is an important step toward advancing vaccines for human use.

Registration now open for International Pandemic Sciences Conference 2025

Representatives from academia, industry, civil society, and the public sector are invited to register for the International Pandemic Sciences Conference 2025, taking place in Oxford and online from 30 June to 1 July 2025.

Optimising testing for disease surveillance with machine learning

A new machine learning-informed strategy could support public health leaders to design better disease surveillance during a disease outbreak.

PSI’s Md Zakiul Hassan recognised as 2024 ISID Emerging Leader

The award from the International Society for Infectious Diseases acknowledges early-career excellence in the field.

Nipah Virus Research Day showcases cross-disciplinary advances

Over 100 researchers convened for a PSI-hosted event exploring the latest interdisciplinary research to combat this deadly virus.

WHO’s Dr Chikwe Ihekweazu shares public health leadership insights at PSI seminar

Launching his new book, the WHO Assistant Director-General and former Director General of the Nigeria Centre for Disease Control (NCDC) shared his experience as a frontline policymaker leading a burgeoning national public health institute in the face of COVID-19.

Partnership with Universiti Malaysia Sabah to advance understanding of emerging viruses

PSI has signed a Memorandum of Understanding with Universiti Malaysia Sabah (UMS), to advance a shared understanding of the risks of emerging viruses in regions rich in biodiversity.

University of Oxford unveils new vaccine development partnership

Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian biotech innovator Univercells.

Load More